Seizure activity and unresponsiveness after hydroxycut ingestion

Area of Science:

• Clinical Toxicology
• Pharmacovigilance

Background:

• Dietary supplements, including those marketed for energy enhancement, muscle building, and fat burning, often contain herbal ingredients.
• Ephedra alkaloids and caffeine are common central nervous system stimulants found in some dietary supplements.
• The United States Food and Drug Administration (FDA) has previously proposed regulations for dietary supplements containing ephedra alkaloids due to safety concerns.

Observation:

• A 22-year-old male experienced seizure-like activity and unresponsiveness following the ingestion of Hydroxycut, a dietary supplement.
• Standard toxicology screening did not reveal common toxins, suggesting an alternative etiology for the adverse event.
• The patient's recent use of Hydroxycut, containing ephedra alkaloids and caffeine, was identified as a potential cause.

Findings:

• Consumption of dietary supplements containing ephedra alkaloids and caffeine was causally linked to the patient's seizure activity.
• The stimulant properties of ephedra alkaloids and caffeine are implicated in the central nervous system excitation leading to seizures.
• This case highlights the potential for serious adverse events associated with unregulated dietary supplements.

Implications:

• Healthcare providers should inquire about the use of dietary supplements, particularly those containing stimulants, during routine patient visits.
• The case underscores the need for enhanced regulatory oversight of herbal and dietary supplements due to potential health risks.
• Increased awareness among consumers and healthcare professionals regarding the risks of ephedra-containing products is crucial for patient safety.